eFFECTOR Therapeutics, Inc. (EFTR)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Aug 21, 2025, 4:00 PM EDT
eFFECTOR Therapeutics Market Cap
eFFECTOR Therapeutics has a market cap or net worth of $941.00 as of August 22, 2025. Its market cap has decreased by -99.99% in one year.
Market Cap
941.00
Enterprise Value
-5.13M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 1, 2021, eFFECTOR Therapeutics's market cap has decreased from 218.96M to 941.00, a decrease of -100.00%. That is a compound annual growth rate of -93.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 941.00 | - |
| Dec 31, 2024 | 941.00 | -100.00% |
| Dec 29, 2023 | 30.20M | 68.61% |
| Dec 30, 2022 | 17.91M | -94.64% |
| Dec 31, 2021 | 334.28M | 52.66% |
| Mar 1, 2021 | 218.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |